Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2025-12-25 @ 4:53 AM
NCT ID:
NCT06830018
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years and ≤75 years.
* Eastern Cooperative Oncology Group (ECOG) physical status score of 0-2.
* Expected survival ≥ 6 months.
* Locally advanced or metastatic gastric/gastroesophageal junction (G/GEJ) adenocarcinoma or colorectal adenocarcinoma not amenable to radical treatment with histologic or cytologic confirmation.
* No prior systemic systemic antitumor therapy for gastric/gastroesophageal junction (G/GEJ) adenocarcinoma or colorectal cancer.
* Have at least one measurable tumor lesion according to RECIST v1.1.
* Compliance with a Fatigue Visual Analog Scale (VAS) score of ≥ 4 (consistent with moderate or severe fatigue).
* Complain of anorexia.
* Good organ function as determined by the following requirements.
Exclusion Criteria:
* Suffered significant surgery or traumatic injuries within the past 1month.
* Having any condition that affects gastrointestinal absorption, such as dysphagia, malabsorption, or uncontrollable vomiting.
currently undergoing tube feeding or parenteral nutrition.
* Suffering from anorexia due to neurosis, mental illness, or difficulty eating due to pain.
* Received erythropoietin or blood transfusion within the past 1month.
* Comorbidities such as serious cerebrovascular, heart, kidney, or liver disease.
* A history of hypersensitivity to the components of the trial medication.
* Other conditions that were considered inappropriate as determined by the investigators.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06830018
Study Brief:
Protocol Section:
NCT06830018